Search | Page 2 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Refining a Biobehavioral Intervention to Enhance Recovery Following Hematopoietic Stem Cell Transplantation

    ... intervention to improve the recovery following hematopoietic stem cell transplantation (HSCT). Cancer patients who were treated with HSCT ... University of Wisconsin Carbone Cancer Center (UWCCC) Autologous transplant recipients with multiple myeloma or lymphoma (both ...

    Clinical Trial last updated 04/29/2016 - 10:30am.

  2. Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases

    ... guideline for HLA -Haploidentical hematopoietic stem cell transplant (HSCT) using a reduced intensity conditioning (RIC) ... that has failed or patients who are ineligible for an autologous transplant. Chronic lymphocytic leukemia/small lymphocytic ...

    Clinical Trial last updated 06/06/2016 - 10:54am.

  3. Transplantation

     

    Page last updated 01/20/2015 - 4:45pm.

  4. Preventing Stem Cell Transplant Complications With a Blood Separator Machine

    ... Background: - Researchers are working to make stem cell transplant procedures safer and more effective. One complication ... OR 5.1.2.9 Hodgkin's Lymphoma relapsing following an autologous transplant. OR 5.1.2.10 Other rare hematologic malignancies for ...

    Clinical Trial last updated 05/23/2016 - 10:57am.

  5. GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

    ... GVHD is one of the most common complications of a stem cell transplant . Status:  ... following a 1st remission who are not candidates for autologous transplants or transplants requiring the use of calcineurin ...

    Clinical Trial last updated 04/29/2016 - 12:40pm.

  6. Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

    ... refractory disease, or relapse (including relapse post autologous hematopoietic stem cell transplant ). Double hit lymphomas in first remission or more ...

    Clinical Trial last updated 06/06/2016 - 12:58pm.

  7. Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    ... This phase II trial studies how well donor peripheral blood stem cell (PBSC) transplant works in treating patients with hematologic ... of multi-agent chemotherapy and are ineligible for an autologous transplant Marginal zone B-cell lymphoma or follicular lymphoma ...

    Clinical Trial last updated 04/29/2016 - 3:26pm.

  8. Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

    ... third complete remission, or relapse (including relapse post autologous hematopoietic stem cell transplant ). Relapsed double hit lymphomas. Patients with options ...

    Clinical Trial last updated 06/06/2016 - 10:28am.

  9. Midostaurin and Azacitidine in Treating Elderly Patients With Acute Myelogenous Leukemia

    ... of cytotoxic treatment; patients who have received prior autologous or allogeneic stem cell transplantation are not eligible; patients may have received 1 or 2 ...

    Clinical Trial last updated 06/03/2016 - 2:24pm.

  10. RIC Transplant Using Haplo Donors

    ... -mismatched first-degree relatives utilizing PBSC as the stem cell source. The primary objective of the study is to estimate the ... failed to respond adequately to conventional-dose therapy or autologous transplantation Myeloproliferative diseases (myelofibrosis, ...

    Clinical Trial last updated 04/29/2016 - 10:52am.